ELIZABETH BROWNLIE: Open Payments
NPI 1295076610 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 73 payments from 12 companies in 2025. Trend: 2023 $420 · 2024 $1,323 · 2025 $1,423
Food & beverage: $1,411Education: $11
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 25 | $525 |
| Axsome Therapeutics, Inc. | 15 | $224 |
| ABBVIE INC. | 7 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $191 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Novo Nordisk Inc | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| PFIZER INC. | 2 | $29 |
| Radius Health, Inc. | 1 | $25 |
Products named: Korlym, Auvelity, CAPLYTA, QULIPTA, UBRELVY, AIRSUPRA, XIFAXAN, BREZTRI.
Industry payments across TN — which companies pay providers there.
